Mirador Biomedical
Latest round
- Series B
Last raised
- Jan 2011
Total raised
- $1.5M
Investors
- 2
About Mirador Biomedical
Mirador Biomedical, founded in 2009 and headquartered in Seattle, US, develops advanced medical devices. The company has undergone significant changes, becoming part of Centurion Medical Products in October 2014. The founder's previous history is not disclosed.Mirador Biomedical, now part of Centurion Medical Products, specializes in advanced medical devices aimed at improving vascular access procedures. Their flagship product, the Compass™ pressure measurement device, is designed to enhance safety during vascular access by preventing inadvertent arterial cannulation, a common complication in procedures such as thoracentesis and lumbar puncture. The Compass device operates by providing real-time pressure readings, which enables healthcare professionals to make informed decisions during these critical procedures. The primary end users of this technology include physicians and medical personnel in hospitals and clinics, particularly in the United States and select international markets.Revenue for Mirador Biomedical is generated through direct sales of its medical devices, primarily the Compass™ pressure measurement systems, to healthcare institutions. The company engages in a business-to-business (B2B) model, supplying hospitals and clinics that require safe and effective vascular access solutions. Transactions are structured as outright purchases, with institutions integrating the devices into their existing medical practices. Partnerships with medical supply distributors may also facilitate product reach in various geographical markets. Pricing models are tailored to institutional needs, reflecting the specialized nature of the Compass devices, although specific pricing details are not disclosed.Following its acquisition by Centurion Medical Products, Mirador Biomedical is expected to leverage resources for future growth. The company aims to expand its product line with new innovations in vascular access technology, although specific upcoming products and release dates have not been detailed. Geographically, Mirador seeks to penetrate additional international markets beyond the US, targeting regions with growing healthcare needs by 2025.
Who invested in Mirador Biomedical
2 investors across 1 round
See all investors in Mirador Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 31, 2011
Amount
$1.5M
Investors
Questions about Mirador Biomedical
Who invested in Mirador Biomedical?
Mirador Biomedical has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mirador Biomedical raised?
Mirador Biomedical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mirador Biomedical last raise money?
Mirador Biomedical's most recent round on record is a Series B, in Jan 2011.
What does Mirador Biomedical do?
Mirador Biomedical, founded in 2009 and headquartered in Seattle, US, develops advanced medical devices.
Where is Mirador Biomedical headquartered?
Mirador Biomedical is headquartered in Seattle, US.
Which VCs invest in companies like Mirador Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Mirador Biomedical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Mirador Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.